Non-inferiority trials
Hinneburg, I.
Medizinische Monatsschrift für Pharmazeuten 39(4): 160-161
2016
ISSN/ISBN: 0342-9601 PMID: 27209896 Document Number: 688784
More and more clinical trials for new drugs are designed as non-inferiority trials. In order to assess the validity of these trials, however, a number of peculiarities have to be considered. This applies, e.g., to the exact definition of "non-inferiority" as well as to the data evaluation methods.
Document emailed within 1 workday
Related Documents
Bonnet, M.; Bhatt, N.; Baudin, E.; Silva, C.; Michon, C.; Taburet, A.-M.; Ciaffi, L.; Sobry, A.ès.; Bastos, R.; Nunes, E.; Rouzioux, C.; Jani, I.; Calmy, A.; Gudo, P.S.; Okamura, J.é L.M.; Lab, M.L.B.; Barreto, A.; Diallo, A.; Nhadzombo, M.; Sitoe, F.; Nhumaio, D.ár.; Bule, O.; Tandaucane, J.é; Guiloviça, V.ân.; Meggi, B.; Sitoe, N.ád.; Vubil, A. 2013: Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial LANCET. Infectious Diseases 13(4): 303-312Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Mumtaz, Z.; Salway, S.; Bhatti, A.; McIntyre, L. 2014: Addressing invisibility, inferiority, and powerlessness to achieve gains in maternal health for ultra-poor women Lancet 383(9922): 1095-1097
Olavarrieta, C.Diaz.; Ganatra, B.; Sorhaindo, A.; Karver, T.S.; Seuc, A.; Villalobos, A.; García, S.G.; Pérez, M.; Bousieguez, M.; Sanhueza, P. 2015: Nurse versus physician-provision of early medical abortion in Mexico: a randomized controlled non-inferiority trial Bulletin of the World Health Organization 93(4): 249-258
Atukunda, E.C.; Siedner, M.J.; Obua, C.; Mugyenyi, G.R.; Twagirumukiza, M.; Agaba, A.G. 2014: Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial Plos Medicine 11(11): E1001752
Raksakietisak, M.; Umpornchote, H.; Chumpathong, S.; Siriussawakul, A.; Napachote, T.; Ladda, P.; Paongchan, S. 2016: The Efficacy of Two Oxygen Therapy Devices (Nasal Cannula vs. Simple Mask) for Preventing Hypoxemia after General Anesthesia: A Randomized Controlled Non-Inferiority Trial of 500 Patients Journal of the Medical Association of Thailand 99(5): 469-476
Webster, G.F.; Leyden, J.J.; Gross, J.A. 2014: Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne Journal of Drugs in Dermatology: Jdd 13(6): 665-670
Beksinska, M.E.; Piaggio, G.; Smit, J.A.; Wu, J.; Zhang, Y.; Pienaar, J.; Greener, R.; Zhou, Y.; Joanis, C. 2013: Performance and safety of the second-generation female condom (FC2) versus the Woman's, the VA worn-of-women, and the Cupid female condoms: a randomised controlled non-inferiority crossover trial Lancet. Global Health 1(3): E146-E152
Beksinska, M.E.; Piaggio, G.; Smit, J.A.; Wu, J.; Zhang, Y.; Pienaar, J.; Greener, R.; Zhou, Y.; Joanis, C. 2013: Performance and safety of the second-generation female condom (FC2) versus the Woman's, the VA worn-of-women, and the Cupid female condoms: a randomised controlled non-inferiority crossover trial Lancet. Global Health 1(3): E146-E152
Li, Y.-s. 2010: To modify the design of preclinical trials: a lesson from the failure of neuroprotection trials in stroke Zhonghua Nei Ke Za Zhi 49(9): 733-734
Cheson, B.D.; Phillips, P.H.; Trimble, E. 1994: Clinical trials. Referral resource. Phase Ii Ovarian Cancer Trials Oncology 8(4): 73-74
Dhalla, S.; Poole, G. 2014: Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention Human Vaccines and Immunotherapeutics 10(7): 1974-1984
Trimble, E.L.; Schoenfeldt, M. 2004: Clinical trials referral source. Current randomized phase IIi trials in gynecologic cancer Oncology 18(13): 1642; 1645-1646
Cheson, B.D.; Carter, C.L.; Sznol, M. 1993: Clinical trials referral resource. NCI-sponsored trials of interleukin-6 (IL-6) Oncology 7(6): 43-44
Saxman, S.B.; Smiley, J.K.; Cheson, B.D. 1999: Clinical trials referral resource. Current trials in melanoma Oncology 13(9): 1239-1242
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
Moher, D. 1998: CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials JAMA 279(18): 1489-1491
Bergmann, J.F.; Lagier, G.; Calvo, F.; Chazelle, F.; Caulin, C. 1988: Independent controls of quality in therapeutic trials. Apropos of an experience of 11 external audits of clinical investigators performed in 2 European multicenter trials Therapie 43(5): 379-384
Ivers, N.M.; Taljaard, M.; Dixon, S.; Bennett, C.; McRae, A.; Taleban, J.; Skea, Z.; Brehaut, J.C.; Boruch, R.F.; Eccles, M.P.; Grimshaw, J.M.; Weijer, C.; Zwarenstein, M.; Donner, A. 2011: Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8 Bmj 343: D5886